Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCHE | P06276 | 2/20 | 0.75 |
| ▸ | GUSB | P08236 | 1/20 | 0.75 |
| ▸ | MAOB | P27338 | 7/20 | 0.67 |
| ▸ | AR | P10275 | 1/20 | 0.66 |
| ▸ | MAPT | P10636 | 5/20 | 0.62 |
| ▸ | CHRNA7 | P36544 | 4/20 | 0.60 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.59 |
| ▸ | NPC1 | O15118 | 1/20 | 0.59 |
| ▸ | LMNA | P02545 | 1/20 | 0.59 |
| ▸ | CASP3 | P42574 | 1/20 | 0.59 |
| ▸ | RAB9A | P51151 | 1/20 | 0.59 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.59 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.59 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.59 |
| ▸ | MAOA | P21397 | 3/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8101054 | 1.00 | BCHE (0.75) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL4865615 | 0.88 | BCHE (0.56) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL28814893 | 0.87 | BCHE (0.75) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL130475 | 0.86 | BCHE (1.00) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL660339 | 0.86 | BCHE (1.00) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL17975272 | 0.84 | CHRNA7 (0.76) | MAPTCHRNA7CYP2C19KDM4ESMN1; SMN2 | |
| SCHEMBL31398696 | 0.84 | CHRNA7 (0.76) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL31398711 | 0.84 | CHRNA7 (0.76) | BCHEGUSBMAOBARMAPT | |
| SCHEMBL31436375 | 0.83 | NR1H4 (0.57) | BCHEGUSBARMAPTCHRNA7 | |
| SCHEMBL30736502 | 0.83 | NR1H4 (0.57) | BCHEGUSBARMAPTCHRNA7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108883041-B | Personal care compositions comprising hair repair blends | ELC 管理有限责任公司 | 2022-03-01 | — | — | CN | claimed |
| EP-3407858-B1 | A METHOD FOR TREATING THE APPEARANCE OF THINNING HAIR | ELC MAN LLC (US) | 2021-10-13 | — | — | EP | claimed |
| EP-3407857-B1 | PERSONAL CARE COMPOSITION COMPRISING A HAIR RESTORATIVE BLEND | ELC MAN LLC (US) | 2020-10-28 | — | — | EP | claimed |
| US-20200268770-A1 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | MONKAM NITCHEU GUY FAUSTIN (FR) | 2020-08-27 | — | — | US | claimed |
| EP-3565536-A1 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | Monkam Nitcheu, Guy Faustin (FR) | 2019-11-13 | — | — | EP | claimed |
| WO-2018127748-A1 | PHARMACEUTICAL COMPOSITION USED FOR TREATING METABOLIC SYNDROME DISORDERS, INFECTIOUS DISEASES, AND COMPLICATIONS THEREOF | MONKAM NITCHEU GUY FAUSTIN (FR) | 2018-07-12 | — | — | WO | claimed |
| CN-107115414-A | Nutriment for preventing and treating diabetes B is combined | 刘新丰 | 2017-09-01 | — | — | CN | claimed |
| EP-3038474-A1 | NUTRACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF TYPE 2 DIABETES | Liu, Charles H. (US) | 2016-07-06 | — | — | EP | claimed |
| US-20160166631-A1 | NUTRACEUTICAL COMBINATION FOR PREVENTION AND TREATMENT OF TYPE 2 DIABETES | LIU CHARLES H (US) | 2016-06-16 | — | — | US | claimed |
| US-20150140135-A1 | METHOD OF USING DIETARY SUPPLEMENTS COMPRISING CINNAMON EXTRACTS TO PROMOTE WEIGHT LOSS | IN INGREDIENTS, INC. (US) | 2015-05-21 | — | — | US | claimed |
| JP-2009531331-A | — | — | 2009-09-03 | — | — | JP | claimed |
| EP-2015645-A2 | EXTRACTS AND METHODS COMPRISING CINNAMON SPECIES | Herbalscience Singapore Pte. Ltd. (US) | 2009-01-21 | — | — | EP | claimed |
| US-20080317886-A1 | Compositions for Preventing and Reducing Delayed Onset Muscle Soreness | SOUTHWEST IMMUNOLOGY, INC. | 2008-12-25 | — | — | US | claimed |
| EP-1973426-A2 | COMPOSITIONS FOR PREVENTING AND REDUCING DELAYED ONSET MUSCLE SORENESS | Southwest Immunology Inc. (US) | 2008-10-01 | — | — | EP | claimed |
| US-20080063689-A1 | Dietary supplements containing anthocyanins and methods for using same to enhance creatine absorption and vasodilation | FARBER MIKE | 2008-03-13 | — | — | US | claimed |
| US-20070292540-A1 | Extracts and Methods Comprising Cinnamon Species | HERBALSCIENCE SINGAPORE PTE. LTD. (SG) | 2007-12-20 | — | — | US | claimed |
| WO-2007109804-A2 | EXTRACTS AND METHODS COMPRISING CINNAMON SPECIES | HERBALSCIENCE SINGAPORE PTE. LTD. (US) | 2007-09-27 | — | — | WO | claimed |
| WO-2007056176-A2 | COMPOSITIONS FOR PREVENTING AND REDUCING DELAYED ONSET MUSCLE SORENESS | SOUTHWEST IMMUNOLOGY, INC. (US) | 2007-05-18 | — | — | WO | claimed |
| US-6967030-B2 | Formulation for insulin and glucose control | WRIGHT JONATHAN V | 2005-11-22 | — | — | US | claimed |
| US-20040137090-A1 | Formulation for insulin and glucose control | WRIGHT JONATHAN V (US) | 2004-07-15 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070292540-A1 | Extracts and Methods Comprising Cinnamon Species | MT-CO2, CA7, CES2 | BCHE 570/4885GUSB 47/4885MAOB 3106/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.